This study evaluates the association between blood pressure (BP) and the risk of developing cardiovascular disease (CVD) events in the elderly. The Morton Plant Mease Foundation has followed 4008 elderly patients 464 years of age for at least 5 years. Systolic and diastolic blood pressure (SBP and DBP) was divided into categories. Cardiovascular disease events were classified as myocardial infarction, stroke, and CVDrelated deaths reported from the National Death Index. Cox proportional hazard ratios were used to assess the relationship between BP and CVD events and controlled for weight, gender, smoker, and alcohol use. Ages o75 and X75 years were assessed separately. After 11.1 years of follow-up, elevated SBP (P ¼ o0.0001) is strongly associated with developing a future CVD event; the relationship is linear and graded and holds for ages above and below 75 years. The frequency of CVD events was lowest in the SBP o120 mm Hg group. In subjects o75 years of age, DBP elevations were not a significant risk factor for CVD events. (relative risk (RR): DBP 70 to o80 mm Hg ¼ 0.92; DBP 80 to o90 mm Hg ¼ 0.88; DBP X90 mm Hg ¼ 1.02.) With subjects X75 years of age, a DBP between 80 and 90 is associated with the lowest significant risk for CVD (RR: DBP 70 to o80 mm Hg ¼ 0.74; DBP 80 to o90 mm Hg ¼ 0.59; DBP X90 ¼ 0.71). In conclusion, these findings support the Joint National Committee on Hypertension recommendations for SBP in the elderly. Further studies are warranted to identify optimal DBP for the elderly at various ages.
Background
In middle-aged adults, the relationship between blood pressure (BP) and cardiovascular events has been shown to be consistent, linear, graded, and independent. [1] [2] [3] [4] Hypertension therapy has produced clear improvements in health outcomes 5 and has resulted in national guidelines for the treatment of hypertension.
Studies on BP and cardiovascular events in the elderly have shown less consistent relationships and results. While some studies have noted a linear relationship between both systolic and diastolic blood pressure (SBP and DBP) and cardiovascular disease (CVD) event rates in the elderly, 6 ,7 a linear SBP association and a J-shaped DBP relationship has been noted with CVD events in other studies. 8, 9 In the elderly, some disagreement has surrounded the importance of monitoring and treating SBP, DBP, or both, as well as whether to treat isolated and/or borderline isolated systolic hypertension. 7, [10] [11] [12] [13] Further, in the very elderly, older than 80 years, BP elevations have shown an association with better survival. [14] [15] [16] Despite these areas of controversy, treatment is commonly recommended for identified hypertension in the elderly and in middle-aged adults, as participants with stage 1 or 2 hypertension have shown that lowering systolic pressure by 10-12 mm Hg and diastolic pressure by 5-6 mm Hg reduces CVD event rates. Recent surveys indicate that BP measurements still exceed recommended levels for most patients. 17 Further research is also warranted in the elderly to clarify how far systolic and DBP should optimally be lowered.
This study aims to assess the value of systolic and diastolic BP as a predictor of CVD events in the elderly, to compare our findings with the current Joint National Committee on Hypertension (JNC-7) recommendations, and to help identify optimal BP goals for the elderly. This study will assess risk for all participants and for the groups with age X75 and o75 years, separately. This study has been well characterized previously. [18] [19] [20] [21] All participants were self-selected and gave informed consent to participate, and the Morton Plant Mease Institutional Review Board approved this study. Inclusion criteria included those participants with at least five visits including baseline. After excluding 253 participants with missing data, 4807 participants remained; 65% were women, and all were over 64 years with a mean entry age of 71.8 years. Table 1 provides demographics on this group. Of these participants, 791 had reported a prior myocardial infarction (MI), history of angina, or stroke and were excluded from these analyses.
Participants and methods

Study population
Thus, 4008 participants (Table 1 ) with a mean age of 71.8 years, without a previous diagnosis of CVD, were assessed over a mean of 11.1 years for the risk of developing a future CVD event. At entry, 28% of the 4008 participants were 75 years of age or older. Of the 4008 study participants noted in the year 2002, 1344 (33.5%) were still being followed in the study, 2277 (56.8%) were reported as dead, and 387 (9.6%) had withdrawn from the study.
Survey methods Blood pressure. Four BP measurements were taken annually on the participants: sitting (left and right), lying, and standing. The BP measurements were taken using an appropriately sized BP cuff and aneroid sphygmomanometer, and generally the left sitting BP was entered in this database.
Systolic and diastolic BP were divided into categories: diastolic as o70, X70-o80, X80-o90, and X90 mm Hg; systolic as o120, X120-140, 4140-160, 4160-180, 4180-240 mm Hg.
Study end points
Cardiovascular disease events represent the primary outcome measure for this study and include selfreported MI and stroke, and CVD-related death. The self-reported stroke and MI data provided from the questionnaires were validated by two separate reviews of medical record reports. The first showed substantial agreement for diagnoses of cancer, diabetes, hypertension, MI, and stroke (k ¼ 0.72, 0.93, 0.71, 0.70, and 0.85). 22 In a second validation between the selfreported events and documented events in this study completed in July 2000 by medical record review, k-statistics ranged from 0.786 to 1.0 for the four diagnoses of hypertension, MI, angina, and stroke. The diagnosis with the highest level of agreement was stroke (k ¼ 1.0), followed by MI (k ¼ 0.845), hypertension (k ¼ 0.829), and angina (k ¼ 0.786).
Data from the National Death Index included deaths listed by International Classification of Diseases (ICD) diagnoses for CVD-related events.
Confounding variables
Confounding factors included age, gender, tobacco use, alcohol use, and body mass index (BMI). A binary variable was created to identify participants 75 years of age and older at baseline (0 ¼ o75 years and 1 ¼ 75 years or more). Additional age cutoffs were examined; however, the number of participants at baseline was not large enough for analysis.
Binary variables were created for the following:
Participant's height and weight (without shoes) were measured by an examiner utilizing a Detecto (Cardinal/Detecto, Webb City, MO, USA) scale and recorded in inches and pounds. Body mass index was grouped as o18.5, 18.5-o22.9, 22.9-24.9, 25-26.9, 27-29.9, and X30 kg/m 2 . Body mass index was classified according to the World Health Organization (WHO) classification with underweight defined as BMI o18.5 kg/m 2 , normal weight as BMI X18.5 and o25 kg/m 2 , overweight as BMI X25 and o30 kg/m 2 , obese as BMI X30 kg/m 2 .
Statistical analysis
Data were analyzed using SAS software (SAS Institute, Cary, NC, USA) and S-Plus software analysis was used to determine if an association existed between future CVD events and BMI, SBP, and DBP using the previously described categories. Cox proportional hazard analyses were run hierarchically to examine the effect of confounding variables in the relationship between BP and cardiovascular events. The first model examined the effect of SBP and DBP as continuous variables on cardiovascular events. An analysis was run with SBP and DBP as categorical variables, as described previously, which increased the significance of the model.
Given the role obesity has on BP, the second model examines the effect of obesity on cardiovascular events. Finally, gender, smoking status, and alcohol consumption were added to determine any mediating effects. Cox models were used to obtain risk ratios and confidence intervals for cardiovascular events in an elderly cohort.
Results
After a mean of 11.1 years of follow-up in those elderly without a prior CVD event at entry, SBP (P ¼ o0.0001) is strongly associated with CVD event rates for the total sample and for the younger participants (o75 years of age at baseline). While an association for SBP and CVD events persists for the older participants (75 years of age and older at baseline), it is not as strong (Po0.05) as with those 65-75 years of age (Table 2) . For the total sample and the younger group, DBP was associated with CVD (P ¼ o0.0001). There was not an overall association between DBP and risk for CVD events in the older age group (P ¼ 0.22) when examined using w 2 table analysis (Table 3) . Table 4 presents the results for cardiovascular events for the total sample and by age categories. Results for the total sample (three models) are presented first followed by the younger age group (age 464 and o75 years) and the older age group (ageX75 years 
Discussion
These findings show that, in the elderly, SBP is strongly associated with the risk of developing future CVD events. These findings also suggest that, down to a SBP of 120 mm Hg, the lower the BP the better in reducing the risk of CVD events in the elderly, especially for ages 464 and o75 years. As such, these findings support the JNC-7 recommendations that SBP should be less than 120 mm Hg in the elderly.
The initial w 2 analyses suggest a subtle linear relationship between DBP and CVD events. For those participants 464 and o75 years of age, once age, gender, BMI, tobacco, and alcohol use were controlled for using Cox Proportional Hazards, DBP was not associated with a significant elevated risk for CVD. For participants X75 years of age, a U-shaped relationship between DBP and CVD events occurred, with the lowest risk of CVD events occurring for a DBP between 80 and 90 mm Hg. These findings differ from those noted by the Prospective Studies Collaboration. 23 In the elderly X75 years of age, coronary artery stiffening and DBP below 80 mm Hg could decrease coronary perfusion and account for a higher risk of CVD events. A DBP o70 mm Hg is associated with the highest risk for CVD events in this study.
The findings in this study are consistent with the results of other large observational studies. The National Health and Nutrition Examination Survey (NHANES II) study by Pastor-Barriuso and the SPAA (Studio sulla Pressione Arteriosa nell'Anziano) Italian BP measurement study 24 both noted a linear, graded, and consistent relationship between systolic pressure and the incidence of CVD events. These studies also failed to note a linear relationship between DBP and CVD events. While the Cardiovascular Health Study (CHS) observed that DBP had a linear relationship with CVD events in the elderly, the relationship between SBP and CVD events was much stronger than that seen with DBP.
For the age group 75 years and older, there was a slight decline in risk for SBP 4180 mm Hg when compared to SBP o180 mm Hg (Po0.05). This finding, although statistically significant, could be misleading as only 69 participants of the participants X75 years of age had an SBP 4180 mm Hg. However, these findings are consistent with previous work by Goodwin et al. [14] [15] [16] noting that very high SBP in the very elderly (480 years of age) may indicate a lack of pre-existing serious disease and may even be protective against overall mortality.
We did not see any evidence for a J-shaped curve for SBP and CVD events. A J-shaped curve with low BP levels being associated with an increased risk for CVD events may be a reflection of concurrent CVD, and our exclusion of participants with a prior diagnosis of CVD may have eliminated the observation of a J-shaped relationship in our study.
As the CHS and the NHANES II studies have noted, pulse pressure has not added to the predictability for future CVD events when systolic and diastolic values are available. Further, pulse pressure values are not commonly used in clinical practice; therefore, we did not include pulse pressure measure analyses in this study.
This study has several limitations. In particular, we did not control for medication use or dietary interventions to control BP. Also, to exclude participants with significant antecedent disease, we included only those participants with five visits, which limits the application of these results to elderly patients without major health problems. Additional limitations are that this study was limited predominately to Caucasians. Therefore, these findings cannot be automatically extended to other ethnic groups. Further, the participants in this study were self-recruited, adding some selection bias. Although using self-reported outcomes may have underestimated the risk associated with BP categories, chart reviews of our data have shown a high level of agreement between the medical history for cardiovascular events and the self-reported data. Lastly, there was also a loss in long-term follow-up in this cohort (9.6%), but considering that a remarkable number of participants completed many years and multiple visits makes this a unique and useful sample.
In summary, SBP is an important predictor of CVD events in the elderly. For ages 464 and o75 years, SBP has a linear and graded relationship with CVD events, and has a stronger relationship with CVD events than DBP. Down to a SBP of 120 mm Hg, the lower the SBP the lower the risk of CVD events. In the very elderly, X75 years of age, SBP also shows a linear relationship with CVD events up to a SBP of 180 mm Hg. A DBP of 80-90 mm Hg appears to convey the lowest risk for CVD events for people X75 years of age.
